Literature DB >> 22522804

Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis.

Yun Sang Cho1, Karen M Dobos, Jessica Prenni, Hongliang Yang, Ann Hess, Ida Rosenkrands, Peter Andersen, Sung Weon Ryoo, Gill-Han Bai, Michael J Brennan, Angelo Izzo, Helle Bielefeldt-Ohmann, John T Belisle.   

Abstract

Purified protein derivative (PPD) has served as a safe and effective diagnostic reagent for 60 years and is the only broadly available material to diagnose latent tuberculosis infections. This reagent is also used as a standard control for a number of in vitro immunological assays. Nevertheless, the molecular composition and specific products that contribute to the extraordinary immunological reactivity of PPD are poorly defined. Here, a proteomic approach was applied to elucidate the gene products in the U.S. Food and Drug Administration (FDA) standard PPD-S2. Many known Mycobacterium tuberculosis T-cell antigens were detected. Of significance, four heat shock proteins (HSPs) (GroES, GroEL2, HspX, and DnaK) dominated the composition of PPD. The chaperone activities and capacity of these proteins to influence immunological responses may explain the exquisite solubility and immunological potency of PPD. Spectral counting analysis of three separate PPD reagents revealed significant quantitative variances. Gross delayed-type hypersensitivity (DTH) responses in M. tuberculosis infected guinea pigs were comparable among these PPD preparations; however, detailed histopathology of the DTH lesions exposed unique differences, which may be explained by the variability observed in the presence and abundance of early secretory system (Esx) proteins. Variability in PPD reagents may explain differences in DTH responses reported among populations.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522804      PMCID: PMC3756804          DOI: 10.1002/pmic.201100544

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  65 in total

1.  Unmatched sequences in public databases - exemplified by tuberculin-active protein.

Authors:  H G Wiker
Journal:  Scand J Immunol       Date:  2004-06       Impact factor: 3.487

2.  Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.

Authors:  Aaron A R Tobian; David H Canaday; Clifford V Harding
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

Review 3.  Tuberculin PPD RT23: still going strong.

Authors:  K Hasløv; S Ponce-de-Leon Rosales; S Rangel-Frausto; S Olesen Larsen
Journal:  Int J Tuberc Lung Dis       Date:  1998-10       Impact factor: 2.373

4.  MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming.

Authors:  M Hirosawa; M Hoshida; M Ishikawa; T Toya
Journal:  Comput Appl Biosci       Date:  1993-04

5.  Amino acid sequence of tuberculin-active protein from Mycobacterium tuberculosis.

Authors:  S Kuwabara
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

6.  Direct analysis of protein complexes using mass spectrometry.

Authors:  A J Link; J Eng; D M Schieltz; E Carmack; G J Mize; D R Morris; B M Garvik; J R Yates
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

7.  Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.

Authors:  S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies.

Authors:  Hiwa Målen; Frode S Berven; Tina Søfteland; Magnus Øverlie Arntzen; Clive S D'Santos; Gustavo Antonio De Souza; Harald G Wiker
Journal:  Proteomics       Date:  2008-05       Impact factor: 3.984

9.  Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins.

Authors:  Ida Rosenkrands; Richard A Slayden; Janne Crawford; Claus Aagaard; Clifton E Barry; Peter Andersen
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  27 in total

Review 1.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

2.  Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Authors:  Patricia A Darrah; Diane L Bolton; Andrew A Lackner; Deepak Kaushal; Pyone Pyone Aye; Smriti Mehra; James L Blanchard; Peter J Didier; Chad J Roy; Srinivas S Rao; David A Hokey; Charles A Scanga; Donata R Sizemore; Jerald C Sadoff; Mario Roederer; Robert A Seder
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

3.  Mycobacterium tuberculosis GroEL2 Modulates Dendritic Cell Responses.

Authors:  Jonathan Kevin Sia; Erica Bizzell; Maria Georgieva; Ranjna Madan-Lala; Jyothi Rengarajan
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

4.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

Review 5.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

6.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 7.  Purified protein derivatives of tuberculin--past, present, and future.

Authors:  Hongliang Yang; Nicole A Kruh-Garcia; Karen M Dobos
Journal:  FEMS Immunol Med Microbiol       Date:  2012-08-01

8.  The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative.

Authors:  Susan L Baldwin; Valerie Reese; Brian Granger; Mark T Orr; Gregory C Ireton; Rhea N Coler; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2014-07-16

9.  Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.

Authors:  Yong Cheng; Jeffery S Schorey
Journal:  Eur J Immunol       Date:  2013-09-06       Impact factor: 5.532

Review 10.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.